161 related articles for article (PubMed ID: 38349517)
1. Postmenopausal onset of androgen excess: a diagnostic and therapeutic algorithm based on extensive clinical experience.
Luque-Ramírez M; Nattero-Chávez L; Rodríguez-Rubio Corona C; Ortiz-Flores AE; García-Cano AM; Rosillo Coronado M; Pérez Mies B; Ruz Caracuel I; Escobar-Morreale HF
J Endocrinol Invest; 2024 Feb; ():. PubMed ID: 38349517
[TBL] [Abstract][Full Text] [Related]
2. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
Hirschberg AL
J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal hyperandrogenism.
Yoldemir T
Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
[TBL] [Abstract][Full Text] [Related]
4. [Hyperandrogenism after menopause: Ovarian or adrenal origin?].
Sarfati J; Moraillon-Bougerolle M; Christin-Maitre S
Gynecol Obstet Fertil Senol; 2022 Oct; 50(10):675-681. PubMed ID: 35609786
[TBL] [Abstract][Full Text] [Related]
5. Management of postmenopausal virilization.
Alpañés M; González-Casbas JM; Sánchez J; Pián H; Escobar-Morreale HF
J Clin Endocrinol Metab; 2012 Aug; 97(8):2584-8. PubMed ID: 22669303
[TBL] [Abstract][Full Text] [Related]
6. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis.
Mamoojee Y; Ganguri M; Taylor N; Quinton R
Clin Endocrinol (Oxf); 2018 Jan; 88(1):13-20. PubMed ID: 28980338
[TBL] [Abstract][Full Text] [Related]
7. Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women.
Bahaeldein E; Brassill MJ
Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 30481153
[TBL] [Abstract][Full Text] [Related]
8. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report.
Chen M; Zhou W; Zhang Z; Zou Y; Li C
Medicine (Baltimore); 2018 Mar; 97(10):e0093. PubMed ID: 29517680
[TBL] [Abstract][Full Text] [Related]
9. Hyperandrogenism after menopause.
Markopoulos MC; Kassi E; Alexandraki KI; Mastorakos G; Kaltsas G
Eur J Endocrinol; 2015 Feb; 172(2):R79-91. PubMed ID: 25225480
[TBL] [Abstract][Full Text] [Related]
10. Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies.
Yance VRV; Marcondes JAM; Rocha MP; Barcellos CRG; Dantas WS; Avila AFA; Baroni RH; Carvalho FM; Hayashida SAY; Mendonca BB; Domenice S
Eur J Endocrinol; 2017 Jul; 177(1):93-102. PubMed ID: 28432270
[TBL] [Abstract][Full Text] [Related]
11. Androgens in Menopausal Women: Not Only Polycystic Ovary Syndrome.
Kostakis EK; Gkioni LN; Macut D; Mastorakos G
Front Horm Res; 2019; 53():135-161. PubMed ID: 31499509
[TBL] [Abstract][Full Text] [Related]
12. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
Waggoner W; Boots LR; Azziz R
Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333
[TBL] [Abstract][Full Text] [Related]
13. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Thresholds for Androgen-Producing Tumors or Pathologic Hyperandrogenism in Women by Use of Total Testosterone Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry.
Sharma A; Kapoor E; Singh RJ; Chang AY; Erickson D
Clin Chem; 2018 Nov; 64(11):1636-1645. PubMed ID: 30068692
[TBL] [Abstract][Full Text] [Related]
15. Approach to androgen excess in women: Clinical and biochemical insights.
Cussen L; McDonnell T; Bennett G; Thompson CJ; Sherlock M; O'Reilly MW
Clin Endocrinol (Oxf); 2022 Aug; 97(2):174-186. PubMed ID: 35349173
[TBL] [Abstract][Full Text] [Related]
16. A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman.
Zhou WB; Chen N; Li CJ
BMC Endocr Disord; 2019 Jan; 19(1):14. PubMed ID: 30674304
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone agonist treatment in postmenopausal women with hyperandrogenism of ovarian origin.
Vollaard ES; van Beek AP; Verburg FA; Roos A; Land JA
J Clin Endocrinol Metab; 2011 May; 96(5):1197-201. PubMed ID: 21307133
[TBL] [Abstract][Full Text] [Related]
18. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal Hyperandrogenism: Evaluation and Treatment Strategies.
Zaman A; Rothman MS
Endocrinol Metab Clin North Am; 2021 Mar; 50(1):97-111. PubMed ID: 33518189
[TBL] [Abstract][Full Text] [Related]
20. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.
Carmina E; Rosato F; Jannì A; Rizzo M; Longo RA
J Clin Endocrinol Metab; 2006 Jan; 91(1):2-6. PubMed ID: 16263820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
